Hormesis mediates dose-sensitive shifts in macrophage activation patterns. (November 2018)

• Record Type: Journal Article
• Authors: Calabrese, Edward J.; Giordano, James J.; Kozumbo, Walter J.; Leak, Rehana K.; Bhatia, Tarun N.
• Is Part Of: Pharmacological research. Volume 137(2018)
• Page Start: 236
• Page End: 249
• Publication Date: 2018-11
• Subjects: Macrophage polarization -- M1 and M2 macrophages -- Hormesis -- Preconditioning -- Reactive oxygen species (ROS) -- Tumor associated macrophage (TAM); Pharmacology -- Periodicals; Pharmacology -- Periodicals; Research -- Periodicals; Médicaments -- Recherche -- Périodiques; Pharmacologie -- Périodiques; 615.105
• DOI: 10.1016/j.phrs.2018.10.010
• Languages: English
• ISSNs: 1043-6618

Abstract

Graphical abstract: Abstract: The activation or polarization of macrophages to pro- or anti-inflammatory states evolved as an adaptation to protect against a spectrum of biological threats. Such an adaptation engages pro-oxidative mechanisms and enables macrophages to neutralize and kill threatening organisms (e.g., viruses, bacteria, mold), limit cancerous growths, and enhance recovery and repair processes. The present study demonstrates that (1) many diverse pharmacological, chemical and physical agents can mediate a dose/concentration-dependent shift between pro- and anti-inflammatory activation states, and (2) these shifts in activation states display biphasic dose-response relationships that are characteristic of hormesis. This study also reveals that preconditioning—another form of hormesis—similarly mediates tissue protection by the polarization of macrophages, but in this case, towards an anti-inflammatory phenotype. This assessment supports the generalizability and significance of hormesis in biology, medicine, and public health and further extends it to encompass the hormetic activation of macrophages.